These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Guidelines for NHL: updates to the management of diffuse large B-cell lymphoma and new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia. Zelenetz AD J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):797-800. PubMed ID: 24853220 [TBL] [Abstract][Full Text] [Related]
5. Four Lymphomas in 1 Patient: A Unique Case of Triple Composite Non-Hodgkin Lymphoma Followed by Classical Hodgkin Lymphoma. Tennese A; Skrabek PJ; Nasr MR; Sekiguchi DR; Morales C; Brown TC; Weisenburger DD; Perry AM Int J Surg Pathol; 2017 May; 25(3):276-280. PubMed ID: 27688525 [TBL] [Abstract][Full Text] [Related]
12. Head and neck squamous cell cancer associated with lymphoproliferative malignancies is aggressive. Li L; Hamilton L; Montgomery J; Stewart M J Laryngol Otol; 2020 May; 134(5):460-462. PubMed ID: 32308160 [TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes. Corradini P; Ladetto M; Zallio F; Astolfi M; Rizzo E; Sametti S; Cuttica A; Rosato R; Farina L; Boccadoro M; Benedetti F; Pileri A; Tarella C J Clin Oncol; 2004 Apr; 22(8):1460-8. PubMed ID: 15084619 [TBL] [Abstract][Full Text] [Related]
14. The therapeutic use of rituximab in non-Hodgkin's lymphoma. Marcus R; Hagenbeek A Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982 [TBL] [Abstract][Full Text] [Related]
15. Hybrid cytogenetics of chronic lymphocytic leukemia and follicular cell lymphoma in a case of non-Hodgkin's lymphoma. Babu Rao V; Kerketta L; Madkaikar M; Farah J; Ghosh K Acta Haematol; 2006; 116(2):150-2. PubMed ID: 16914914 [No Abstract] [Full Text] [Related]
16. ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). Ghielmini M; Vitolo U; Kimby E; Montoto S; Walewski J; Pfreundschuh M; Federico M; Hoskin P; McNamara C; Caligaris-Cappio F; Stilgenbauer S; Marcus R; Trneny M; Dreger P; Montserrat E; Dreyling M; Ann Oncol; 2013 Mar; 24(3):561-76. PubMed ID: 23175624 [TBL] [Abstract][Full Text] [Related]
17. A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas. Feugier P Future Oncol; 2015; 11(9):1327-42. PubMed ID: 25952779 [TBL] [Abstract][Full Text] [Related]
18. Management of non-Hodgkin's lymphomas. Mounter PJ; Lennard AL Postgrad Med J; 1999 Jan; 75(879):2-6. PubMed ID: 10396578 [TBL] [Abstract][Full Text] [Related]